Originator Organization PhoreMost Ltd.Startup |
Active Organization PhoreMost Ltd.Startup |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | GB | PhoreMost Ltd.Startup | 26 Jun 2024 |